Russian Disinformation Campaign Targets Pfizer Vaccine: Report
The Kremlin is reportedly attempting to increase global demand for its homegrown Sputnik V jab by sowing unfounded doubts about the competition.

Dimitar Dilkoff/AFP via Getty
Russian intelligence has been planting disinformation about Pfizer’s COVID-19 vaccine in recent months, pushing misleading claims in four Kremlin-linked publications about the safety and efficacy of the company’s mRNA shot, an unidentified State Department official told The Wall Street Journal. The official said two of the outlets are fronts for the SVR, Russia’s foreign intelligence service; one is controlled by the FSB, which is a successor agency to the KGB; and one is linked to the GRU, which is Russia’s military intelligence service. None of the three vaccines being offered to Americans—developed and manufactured by Moderna, Johnson & Johnson, and Pfizer—have been linked to any serious side effects, and are all highly effective, according to the CDC.
A new report by the Alliance for Securing Democracy, an NGO under the aegis of the German Marshall Fund, explains what it believes is behind the Russian disinfo campaign. “The emphasis on denigrating Pfizer is likely due to its status as the first vaccine besides Sputnik V to see mass use, resulting in a greater potential threat to Sputnik’s market dominance,” it says. A Kremlin spokesman denied the report, blaming the U.S. for overreacting to what amounts to nothing more than a “debate” over vaccines.
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.